Is adagrasib just another sotorasib?—or, should we differentiate their usage according to patients’ clinical presentation?
@article{TLCR74973, author = {Yuko Oya and Tetsuya Mitsudomi}, title = {Is adagrasib just another sotorasib?—or, should we differentiate their usage according to patients’ clinical presentation?}, journal = {Translational Lung Cancer Research}, volume = {12}, number = {5}, year = {2023}, keywords = {}, abstract = {}, issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/74973} }